Articles by Disease (Hematological Malignancies)

Cancer Stem Cells in Hematological Disorders: Current and Possible New Therapeutic Approaches

Journal: Current Pharmaceutical Biotechnology
Volume: 12
Page: 217-225
Author(s): C. Annaloro, F. Onida, G. Saporiti and G. Lambertenghi Deliliers

Cancer Cell Reprogramming: Stem Cell Differentiation Stage Factors and An Agent Based Model to Optimize Cancer Treatment

Journal: Current Pharmaceutical Biotechnology
Volume: 12
Page: 231-242
Author(s): P. M. Biava, M. Basevi, L. Biggiero, A. Borgonovo, E. Borgonovo and F. Burigana

The CXCL12/CXCR4 Axis as a Therapeutic Target in Cancer and HIV-1 Infection

Journal: Current Medicinal Chemistry
Volume: 18
Page: 497-512
Author(s): L. Patrussi and C. T. Baldari

Novel and Emerging Drugs for Acute Myeloid Leukemia: Pharmacology and Therapeutic Activity

Journal: Current Medicinal Chemistry
Volume: 18
Page: 638-666
Author(s): T. Robak, A. Szmigielska-Kaplon, A. Pluta, O. Grzybowska-Izydorczyk, A. Wolska, M. Czemerska and A Wierzbowska

Recent Advances in the Therapeutic Perspectives of Nutlin-3

Journal: Current Pharmaceutical Design
Volume: 17
Page: 569-577
Author(s): Paola Secchiero, Raffaella Bosco, Claudio Celeghini and Giorgio Zauli

Targeting p73 - a Potential Approach in Cancer Treatment

Journal: Current Pharmaceutical Design
Volume: 17
Page: 591-602
Author(s): Neda Slade and Andela Horvat

The Ubiquitin+Proteasome Protein Degradation Pathway as a Therapeutic Strategy in the Treatment of Solid Tumor Malignancies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11
Page: 242-246
Author(s): James J. Driscoll, Alex Minter, Daniel A. Driscoll and Jason K. Burris